CORC

在结果中检索

CORC

浏览/检索结果: 共81条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and P53 期刊论文
出版物, 3111, 期号: 0, 页码: 1-37
作者:  Baihe Chen;  Di Lu;  Yujuan Fu;  Jingwen Zhang;  Xiaobo Huang
收藏  |  浏览/下载：236/0  |  提交时间：2017/07/24
Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis 期刊论文
NATIONAL SCIENCE REVIEW, 2022, 卷号: 9, 期号: 7, 页码: 15
作者:  Jin, Yujuan;  Zhao, Qiqi;  Zhu, Weikang;  Feng, Yan;  Xiao, Tian
收藏  |  浏览/下载：16/0  |  提交时间：2023/02/07
ET White Paper: To Find the First Earth 2.0 预印本
2022
作者:  Ge, Jian;  Zhang, Hui;  Zang, Weicheng;  Deng, Hongping;  Mao, Shude
收藏  |  浏览/下载：35/0  |  提交时间：2022/07/29
Efficient and stable perovskite solar cells thanks to dual functions of oleyl amine-coated PbSO4(PbO)(4) quantum dots: Defect passivation and moisture/oxygen blocking 期刊论文
NANO ENERGY, 2020, 卷号: 68
作者:  Chen, Chong;  Li, Fumin;  Zhu, Liangxin;  Shen, Zhitao;  Weng, Yujuan
收藏  |  浏览/下载：30/0  |  提交时间：2020/11/26
Enhancing the efficiency and stability of perovskite solar cells by incorporating CdS and Cd(SCN2H4)(2)Cl-2 into the CH3NH3PbI3 active layer 期刊论文
JOURNAL OF MATERIALS CHEMISTRY A, 2019, 卷号: 7, 期号: 3, 页码: 1124-1137
作者:  Zhu, Liangxin;  Chen, Chong;  Li, Fumin;  Shen, Zhitao;  Weng, Yujuan
收藏  |  浏览/下载：20/0  |  提交时间：2020/05/21
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：56/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：44/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace